Literature DB >> 26156515

Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.

Carole Dufouil1, Laura Richert2, Rodolphe Thiébaut2, Mathias Bruyand2, Hélène Amieva2, Frédéric-Antoine Dauchy2, Jean-François Dartigues2, Didier Neau2, Philippe Morlat2, Patrick Dehail2, François Dabis2, Fabrice Bonnet2, Geneviève Chêne2.   

Abstract

OBJECTIVE: We investigated the relationship of diabetes and prediabetes with cognitive performances, assessed through raw test and z scores and according to neurocognitive impairment (NCI) classification in a cohort of individuals infected with HIV.
METHODS: The ANRS CO3 Aquitaine cohort is a prospective hospital-based cohort of HIV-1-infected patients under routine clinical management in 6 public hospitals in southwestern France. Between 2007 and 2009, an ancillary study consisted of a neuropsychological battery of 10 tests at baseline and 2-year follow-up. The severity of NCI (normal, asymptomatic, mild, HIV dementia) was assessed according to international guidelines.
RESULTS: At baseline (400 patients, 33 with prediabetes, 39 with diabetes), in cross-sectional multivariable analyses, patients with diabetes performed significantly worse on 9 neuropsychological tests that assessed memory, executive functions, attention, psychomotor speed, language, and manual dexterity. Participants with prediabetes had worse performances compared with those who had normal glycemia in 5 tests. The longitudinal analysis of the association between glycemia status at baseline and change in cognitive performances over 2-year follow-up (n = 283) suggested that patients with diabetes also showed a slightly higher decline on 5 of the 10 tests, those involving executive functions and memory functioning. Glycemia status at baseline was not significantly associated with NCI severity in cross-sectional (p = 0.44) and longitudinal (p = 0.64) analyses.
CONCLUSIONS: In this hospital-based cohort of people living with HIV, diabetes, but not the other cardiovascular risk factors, is associated with worse cognitive performances in several cognitive domains and with larger decline in fewer domains over the short term.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Year:  2015        PMID: 26156515      PMCID: PMC4603596          DOI: 10.1212/WNL.0000000000001815

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Unraveling the puzzle of dementia risk in diabetes.

Authors:  Geert Jan Biessels
Journal:  J Diabetes Complications       Date:  2012-07-24       Impact factor: 2.852

2.  Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidémiologie du SIDA en Aquitaine (GECSA).

Authors:  R Thiébaut; P Morlat; H Jacqmin-Gadda; D Neau; P Mercié; F Dabis; G Chêne
Journal:  AIDS       Date:  2000-05-26       Impact factor: 4.177

3.  Impact of cerebrovascular disease on cognitive function in HIV-infected patients.

Authors:  Beau K Nakamoto; Victor G Valcour; Kalpana Kallianpur; Chin-Yuan Liang; Aaron McMurtray; Dominic Chow; Erin Kappenburg; Cecilia M Shikuma
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

4.  Metabolic syndrome, diabetes, poor cognition, and dementia in the Caerphilly prospective study.

Authors:  Samuel T Creavin; John Gallacher; Antony Bayer; Mark Fish; Shah Ebrahim; Yoav Ben-Shlomo
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

5.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

6.  Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.

Authors:  Jacqueline Capeau; Vincent Bouteloup; Christine Katlama; Jean-Philippe Bastard; Vincent Guiyedi; Dominique Salmon-Ceron; Camelia Protopopescu; Catherine Leport; Francois Raffi; Geneviève Chêne
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

7.  Cardiovascular risk factors and cognitive decline in middle-aged adults.

Authors:  D Knopman; L L Boland; T Mosley; G Howard; D Liao; M Szklo; P McGovern; A R Folsom
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

8.  Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women: the Women's Interagency HIV Study.

Authors:  Victor Valcour; Pauline Maki; Peter Bacchetti; Kathryn Anastos; Howard Crystal; Mary Young; Wendy J Mack; Mardge Cohen; Elizabeth T Golub; Phyllis C Tien
Journal:  AIDS Res Hum Retroviruses       Date:  2011-10-18       Impact factor: 2.205

9.  Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.

Authors:  J A McCutchan; J A Marquie-Beck; C A Fitzsimons; S L Letendre; R J Ellis; R K Heaton; T Wolfson; D Rosario; T J Alexander; C Marra; B M Ances; I Grant
Journal:  Neurology       Date:  2012-02-14       Impact factor: 9.910

10.  Cognitive disorders in HIV-infected patients: are they HIV-related?

Authors:  Fabrice Bonnet; Hélène Amieva; Fabienne Marquant; Charlotte Bernard; Mathias Bruyand; Frédéric-Antoine Dauchy; Patrick Mercié; Carine Greib; Laura Richert; Didier Neau; Gwenaelle Catheline; Patrick Dehail; Francois Dabis; Philippe Morlat; Jean-François Dartigues; Geneviève Chêne
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

View more
  9 in total

1.  Empiric neurocognitive performance profile discovery and interpretation in HIV infection.

Authors:  Daniela Gomez; Christopher Power; M John Gill; Noshin Koenig; Roberto Vega; Esther Fujiwara
Journal:  J Neurovirol       Date:  2018-12-05       Impact factor: 2.643

2.  Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.

Authors:  Alessandra Vergori; Carmela Pinnetti; Patrizia Lorenzini; AnnaClelia Brita; Raffaella Libertone; Ilaria Mastrorosa; Stefania Cicalini; Andrea Antinori; Adriana Ammassari
Journal:  Infection       Date:  2019-06-10       Impact factor: 3.553

Review 3.  HIV-associated neurocognitive disorder.

Authors:  David B Clifford
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

4.  Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients.

Authors:  Massimiliano Fabbiani; Nicoletta Ciccarelli; Valeria Castelli; Alessandro Soria; Alberto Borghetti; Elisa Colella; Davide Moschese; Manuela Valsecchi; Arianna Emiliozzi; Andrea Gori; Andrea De Luca; Alessandra Bandera; Simona Di Giambenedetto
Journal:  J Neurovirol       Date:  2019-07-07       Impact factor: 2.643

Review 5.  Executive Function and Diabetes: A Clinical Neuropsychology Perspective.

Authors:  Qian Zhao; Yonggang Zhang; Xiaoyang Liao; Weiwen Wang
Journal:  Front Psychol       Date:  2020-08-20

6.  HIV/AIDS and an overweight body mass are associated with excessive intra-individual variability in response preparation.

Authors:  Lance O Bauer
Journal:  J Neurovirol       Date:  2018-05-17       Impact factor: 2.643

Review 7.  The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley.

Authors:  Roberto De La Garza; Hansapani Rodrigo; Francisco Fernandez; Upal Roy
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

Review 8.  Prevalence, Risk Factors, and Pathophysiology of Dysglycemia among People Living with HIV in Sub-Saharan Africa.

Authors:  Benson Njuguna; Jepchirchir Kiplagat; Gerald S Bloomfield; Sonak D Pastakia; Rajesh Vedanthan; John R Koethe
Journal:  J Diabetes Res       Date:  2018-05-23       Impact factor: 4.011

9.  Self-Management Model fails to Predict Quality of Life for People Living with Dual Diagnosis of HIV and Diabetes.

Authors:  Julie Ann Zuñiga; Adam Sales; Dong Eun Jang; Chelsi West Ohueri; Greer Burkholder; Richard Moore; Thibaut Davy-Méndez; Katerina Christopoulos; Alexandra A García
Journal:  AIDS Behav       Date:  2021-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.